Article Data

  • Views 1127
  • Dowloads 121

Case Reports

Open Access

Hepatoid carcinoma of the ovary: Characteristics of its immunoreactivity. A case report

  • J.S.H. TSUNG1,*,
  • P.-S. Yang2

1Department of Pathology and Laboratory Medicine, Taiwan

2Department of Surgery Koo Foundation, Sun-Yat Sen Cancer Center and Institute of Pharmacy, School of Medicine, National Yang-Ming University Taipei, Taiwan

DOI: 10.12892/ejgo200406745 Vol.25,Issue 6,November 2004 pp.745-748

Published: 10 November 2004

*Corresponding Author(s): J.S.H. TSUNG E-mail:

Abstract

Alpha-fetoprotein producing tumors other than hepatoma and germ cell tumors have been widely reported, especially in carcinoma with hepatoid differentiation (hepatoid carcinoma). Hepatoid carcinoma has mostly been found in the stomach, but also occurs in many other organs. A rare case of hepatoid carcinoma of the ovary is presented. A 57-year-old Taiwanese woman was admitted because of lower abdominal pain. Magnetic resonance imaging showed a 10 cm right adnexal mass. She underwent a total hysterectomy and bilateral salpingo-oophorectomy with omentectomy. A right ovarian mass measuring 13 x 9 x 8 cm was found. Microscopic examination showed characteristic features for hepatoid carcinoma. Immunohistochemical staining was performed on the tumor using a panel of eight markers (AFP, p-CEA, CD10, Hep Par 1, thyroid transcription factor-1, CK7, CK19 and CK20). This study contradicts the theory that hepatoid carcinoma derives from the surface epithelium of the ovary. Hepatoid carcinoma of the ovary commonly contains a population of clear cells, which may lead to the misdiagnosis of yolk sac tumor or clear cell adenocarcinoma that may arise in many anatomic sites. Histologically, it is also difficult to distinguish hepatoid carcinoma from hepatoid yolk sac tumor. In such cases, demonstration of CD 10, Hep Par 1, membraneous patterns of p-CEA and CK7 would be invaluable for characterizing the tumor as hepatoid carcinoma. More studies are needed to confirm this observation.

Keywords

Hepatoid carcinoma; Alpha-fetoprotein; Hepatocyte antigen; CD 10; p-CEA; Thyroid transcription factor 1

Cite and Share

J.S.H. TSUNG,P.-S. Yang. Hepatoid carcinoma of the ovary: Characteristics of its immunoreactivity. A case report. European Journal of Gynaecological Oncology. 2004. 25(6);745-748.

References

[1] Tshikura H., Fukasawa Y., Ogasarawa K., Natori T., Tsukada Y., Aizawa M.: "An AFP producing gastric carcinoma with features of hepatic differentiation. A case report". Cance,; 1985, 56, 840

[2] Ishikura H., Scully R.E.: "Hepatoid carcinoma of the ovary". Cancer, 1987, 60, 2775.

[3] Myamon E., Piura B., Mazor M., Bashiri A., Siberstein T., Yanai Inbar I.: "Primary hepatoid carcinoma of ovary in pregnancy". Am. J. Obstet. Gynecol., 1998, 179, 820.

[4] Lee C.H., Huang K.G., Ueng S.H., Swei H., Chueh H.Y., Lai C.H.: "A hepatoid carcinoma of the ovary". Acta Obstet. Gynecol Scand., 2000, 81, 1080.

[5] Watanabe Y., Umemoto M., Ueda H., Nakai H., Hoshiai H., Noda K.: "Cytopathologic and clinicopathologic features of ovarian hepatoid carcinoma". Acta Cytologica, 2003, 47, 78.

[6] Tochigi N., Kishimoto T., Supriatana Y., Nagai Y., Nikaido T., Ishikura: "Hepatoid carcinoma of the ovary: a case report of three cases, admixed with a common surface epithelial carcinoma". Int. J. Gynecol. Pathol., 2003, 22, 266.

[7] Trivedi P., Dave K., Shah M., Karelia N., Patel D., Wadhwa M.: "Hepatoid carcinoma of the ovary: a case report". Eur. J Gynaecol. Oneal., 1998, 19, 167.

[8] Scurry J.P., Brown R.W., Jobling T.: "Combined ovarian serous papillary and hepatoid carcinoma". Gynecol. Oneal., 1996, 63, 138.

[9] Wennerberg A.E., Nalenik M.A., Coleman W.B.: "Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors". Am. J. Pathol., 1993, 80, 277.

[10] Borscheri N., Roessner A., Rocken C.: "Canalicular immunostaming of neprilysin (CDIO) as a diagnostic marker for hepatocellular carcinoma". Am. J. Surg. Pathol., 2001, 25, 1297.

[11] Ordonez N.A.:'Thyroid transcription factor is a marker for lung and thyroid carcinoma". Adv. Anat. Pathol., 2000, 7, 123.

[12] Wieczorek R.J., Pinkus J.L., Glickman J.N., Geraldine S., Pinkus S.: "Comparison of thyroid transcription factor-I and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma". Am. J. Clin. Pathol., 2002, 118, 911.

Abstracted / indexed in

Web of Science (WOS) (On Hold)

Journal Citation Reports/Science Edition

Google Scholar

JournalSeek

Submission Turnaround Time

Top